In-vivo experiments using selegiline displacement in patients with Alzheimer’s disease and PSP indicate that [18F]-THK5351 may bind to MAO-B [40], suggesting that [18F]-THK5351 binds to astrogliosis. This evidence concerns the gene MAOB and supranuclear palsy, progressive, 1.